Transplantation of human amnion-derived mesenchymal stem cells alleviates ischemia-reperfusion-induced acute lung injury after cardiopulmonary bypass

doi:10.3969/j.issn.2095-4344.2016.01.013

Abstract

Abstract:

BACKGROUND: In recent years, mesenchymal stem cells exhibit a good prospect in organ or tissue repair and therefore, and therefore, cell transplantation based on mesenchymal stem cell plasticity can promote cell regeneration and functional recovery from lung injury after cardiopulmonary bypass.
OBJECTIVE: To investigate the effects of human amnion-derived mesenchymal stem cells (hAMSCs) transplantation on ischemia-reperfusion-induced acute lung injury in dogs after cardiopulmonary bypassand its mechanism for regulating inflammatory cytokines.
METHODS: Eighteen adult healthy mongrel dogs were randomly divided into three groups (n=6 per group): black group (cardiopulmonary bypass with 1 mL physiological saline injection via the femoral vein without blocking the aorta), control group (cardiopulmonary bypass with blocking the aorta for 1 hour and then opening the aorta for 15 minutes plus 1 mL physiological saline injection via the femoral vein), experiment group (cardiopulmonary bypass with blocking the aorta for 1 hour and then opening the aorta for 15 minutes plus femoral vein injection of 1 mL physiological saline containing 2×107 hAMSCs). Arterial blood samples of 2 mL were taken to calculate oxygenation index and respiratory index before cardiopulmonary bypass (T1), 15 minutes (T2), 1 hour (T3), 2 hours (T4), 3 hours (T5) after opening the aorta. 8 mL intravenous blood samples were taken to detect the serum tumor necrosis factor α, matrix metalloproteinase-9, interleukin-8 and interleukin-10 by ELISA. Meanwhile, western blot assay was used to detect the expression of nuclear factor-κB in lung tissues, and histopathological changes of lung tissues observed under optical microscope.
RESULTS AND CONCLUSION: Compared with the control group, the oxygenation index was significantly increased in the experimental group at 2 and 3 hours after transplantation, and the respiratory index was remarkably decreased at 1, 2, 3 hours after transplantation. Compared with the control group, the levels of tumor necrosis factor α, matrix metalloproteinase-9 and interleukin-8 were significantly decreased in the experimental group, but the level of interleukin-10 was increased in the experimental group. Compared with the blank group, the expression of nuclear factor-κB was significantly strengthened in the control group at 3 hours after opening the aorta, but it was decreased significantly after intravenous injection of hAMSCs. After opening the aorta, the pathological changes in the experimental group were remarkably milder than those in the control group, and a small amount of red blood cells and neutrophils exuded, with telangiectasia, and congestion, were found in the experimental group. These findings indicate that hAMSCs transplantation can mitigate ischemia-reperfusion- induced acute lung injury after cardiopulmonary bypass by adjusting the level of nuclear factor-κB in lung tissues and release of tumor necrosis factor α, matrix metalloproteinase-9, interleukin-8 and interleukin-10.

中国组织工程研究杂志出版内容重点：干细胞；骨髓干细胞；造血干细胞；脂肪干细胞；肿瘤干细胞；胚胎干细胞；脐带脐血干细胞；干细胞诱导；干细胞分化；组织工程

CLC Number:

R394.2

Qiang Yong, Liang Gui-you, Yu Li-mei, Qi Bin, Gao Zhen-yu. Transplantation of human amnion-derived mesenchymal stem cells alleviates ischemia-reperfusion-induced acute lung injury after cardiopulmonary bypass[J]. Chinese Journal of Tissue Engineering Research, 2016, 20(1): 70-77.

Figures/Tables 6

References

[1] Sevuk U, Cakil N, Altindag R, et al. Relationship between nadir hematocrit during cardiopulmonary bypass and postoperative hyperglycemia in nondiabetic patients. Heart Surg Forum. 2014;17(6):E302-307.
[2] Engels M, Bilgic E, Pinto A, et al. A cardiopulmonary bypass with deep hypothermic circulatory arrest rat model for the investigation of the systemic inflammation response and induced organ damage. J Inflamm (Lond). 2014;11:26.
[3] Ranucci M, Isgrò G, Carlucci C, et al. Central venous oxygen saturation and blood lactate levels during cardiopulmonary bypass are associated with outcome after pediatric cardiac surgery. Crit Care. 2010;14(4):R149.
[4] Chen H, Cheng ZB, Yu RG. Procalcitonin as a predictor of moderate to severe acute respiratory distress syndrome after cardiac surgery with cardiopulmonary bypass: a study protocol for a prospective cohort study. BMJ Open. 2014; 4(10):e006344.
[5] Nakamura H, Yamaguchi H, Amano A, et al. Venovenous extracorporeal membrane oxygenation is effective against post-cardiotomy acute respiratory failure in adults. Gen Thorac Cardiovasc Surg. 2013;61(7):402-408.
[6] Cheng C, Li S, Wang Y, et al. Ischemic postconditioning alleviates lung injury and maintains a better expression of aquaporin-1 during cardiopulmonary bypass.Chin Med J (Engl). 2014;127(23):4012-4018.
[7] Dolkart O, E A, S S, et al. Temporal determination of lung NO system and COX-2 upregulation following ischemia-reperfusion injury. Exp Lung Res. 2014;40(1):22-29.
[8] Gu YJ, Boonstra PW, Graaff R, et al. Pressure drop, shear stress, and activation of leukocytes during cardiopulmonary bypass: a comparison between hollow fiber and flat sheet membrane oxygenators.Artif Organs. 2000;24(1):43-48.
[9] Banz Y, Rieben R, Zobrist C, et al. Addition of dextran sulfate to blood cardioplegia attenuates reperfusion injury in a porcine model of cardiopulmonary bypass. Eur J Cardiothorac Surg. 2008;34(3):653-660.
[10] Liakopoulos OJ, Schmitto JD, Kazmaier S, et al. Cardiopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery. Ann Thorac Surg. 2007;84(1):110-118.
[11] Warren O, Darzi A, Athanasiou T. What is the role of leukocyte depletion in cardiac surgery.Heart Lung Circ. 2007;16(5): 398-399.
[12] Eisses MJ, Velan T, Aldea GS, et al. Strategies to reduce hemostatic activation during cardiopulmonary bypass. Thromb Res. 2006;117(6):689-703.
[13] Williams GD, Ramamoorthy C, Chu L, et al. Modified and conventional ultrafiltration during pediatric cardiac surgery: clinical outcomes compared. J Thorac Cardiovasc Surg. 2006;132(6):1291-1298.
[14] Manuelpillai U, Moodley Y, Borlongan CV, et al. Amniotic membrane and amniotic cells: potential therapeutic tools to combat tissue inflammation and fibrosis. Placenta. 2011;32 Suppl 4:S320-325.
[15] Chang CJ, Yen ML, Chen YC, et al. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells. 2006;24(11):2466-2477.
[16] Banas RA, Trumpower C, Bentlejewski C, et al. Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells. Hum Immunol. 2008;69(6):321-328.
[17] Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.
[18] Bailo M, Soncini M, Vertua E, et al. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation. 2004;78(10):1439-1448.
[19] 丛姗,白立恒,李岩,等.人羊膜间充质干细胞移植对CCl4诱导的小鼠损伤肝HGF、SIRT-1、α-SMA及P27kip1表达的影响[J].中国生物化学与分子生物学报, 2015, 31(3):292-300.
[20] Zhao P, Ise H, Hongo M, et al. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation. 2005;79(5):528-535.
[21] Kim J, Kang HM, Kim H, et al. Ex vivo characteristics of human amniotic membrane-derived stem cells. Cloning Stem Cells. 2007;9(4):581-594.
[22] Kim J, Lee Y, Kim H, et al. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif. 2007;40(1):75-90.
[23] Han K, Lee JE, Kwon SJ, et al. Human amnion-derived mesenchymal stem cells are a potential source for uterine stem cell therapy. Cell Prolif. 2008;41(5):709-725.
[24] 丛姗,宋瑾,张惠娟,等.人羊膜间充质干细胞(hAMSCs)的分离、体外培养及诱导分化[J]. 农业生物技术学报,2015,23(1): 20-31.
[25] Gibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery.Minn Med. 1954;37(3): 171-185.
[26] 张贺,王承利,王洋,等.犬体外循环模型建立及麻醉处理[J].中国比较医学杂志,2010,20(10):44-47.
[27] Halter J, Steinberg J, Fink G, et al. Evidence of systemic cytokine release in patients undergoing cardiopulmonary bypass. J Extra Corpor Technol. 2005;37(3):272-277.

[28] Zhou E, Li Y, Wei Z, et al. Schisantherin A protects lipopolysaccharide-induced acute respiratory distress syndrome in mice through inhibiting NF-κB and MAPKs signaling pathways. Int Immunopharmacol. 2014;22(1): 133-140.
[29] Shembade N, Harhaj NS, Liebl DJ, et al. Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling. EMBO J. 2007;26(17):3910-3922.
[30] Karlsson H, Samarasinghe S, Ball LM, et al. Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses. Blood. 2008;112(3):532-541.
[31] Miyazawa T, Matsumoto K, Ohmichi H, et al. Protection of hippocampal neurons from ischemia-induced delayed neuronal death by hepatocyte growth factor: a novel neurotrophic factor. J Cereb Blood Flow Metab. 1998;18(4): 345-348.
[32] Matsumoto K, Nakamura T. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int. 2001;59(6):2023-2038.
[33] Sharma HS. Neuroprotective effects of neurotrophins and melanocortins in spinal cord injury: an experimental study in the rat using pharmacological and morphological approaches. Ann N Y Acad Sci. 2005;1053:407-421.
[34] Fares RC, Gomes Jde A, Garzoni LR, et al. Matrix metalloproteinases 2 and 9 are differentially expressed in patients with indeterminate and cardiac clinical forms of Chagas disease. Infect Immun. 2013;81(10):3600-3608.
[35] Välimäki J, Uusitalo H. Matrix metalloproteinases (MMP-1, MMP-2, MMP-3 and MMP-9, and TIMP-1, TIMP-2 and TIMP-3) and markers for vascularization in functioning and non-functioning bleb capsules of glaucoma drainage implants. Acta Ophthalmol. 2015;93(5):450-456.
[36] Toufaily C, Charfi C, Annabi B, et al. A Role for the Cavin-3/Matrix Metalloproteinase-9 Signaling Axis in the Regulation of PMA-Activated Human HT1080 Fibrosarcoma Cell Neoplastic Phenotype. Cancer Growth Metastasis. 2014; 7:43-51.
[37] Petrovska-Cvetkovska D, Dolnenec-Baneva N, Nikodijevik D, et al. Correlative study between serum matrix metalloproteinase 9 values and neurologic deficit in acute, primary, supratentorial, intracerebral haemorrhage. Prilozi. 2014;35(2):39-44.
[38] Wang C, Li D, Qian Y, et al. Increased matrix metalloproteinase-9 activity and mRNA expression in lung injury following cardiopulmonary bypass. Lab Invest. 2012; 92(6):910-916.
[39] Eichler W, Bechtel JF, Schumacher J, et al. A rise of MMP-2 and MMP-9 in bronchoalveolar lavage fluid is associated with acute lung injury after cardiopulmonary bypass in a swine model. Perfusion. 2003;18(2):107-113.
[40] Bours V, Bentires-Alj M, Hellin AC, et al. Nuclear factor-kappa B, cancer, and apoptosis. Biochem Pharmacol. 2000;60(8): 1085-1089.
[41] Xiao W. Advances in NF-kappaB signal ling transduction and transcription. Cell Mol Immunology. 2004;1(6):425-435.
[42] Fei XJ, Zhu LL, Xia LM, et al. Acanthopanax senticosus attenuates inflammation in lipopolysaccharide-induced acute lung injury by inhibiting the NF-κB pathway. Genet Mol Res. 2014;13(4):10537-10544.